Press Releases

Jan 08, 2024 7:18am EST

CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California

Jan 02, 2024 7:00am EST

CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants

Nov 29, 2023 7:00am EST

CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023

Nov 09, 2023 8:00am EST

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Nov 01, 2023 7:05am EDT

CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler

Sep 21, 2023 7:00am EDT

CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative

Sep 05, 2023 7:00am EDT

CollPlant to Present at the H.C. Wainwright Annual Growth Conference

Aug 24, 2023 7:00am EDT

CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million

Aug 09, 2023 8:00am EDT

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Jun 26, 2023 7:00am EDT

CollPlant Achieves Milestone and To Receive $10 Million From AbbVie in Accordance with its Regenerative Dermal Filler Product Collaboration Agreement